FDA Grants Tentative Approval For Aurobindo's Antiretroviral Drug Abacavir
Sat, 27 May 2006 01:00 AM EST
... Indian drug manufacturer Aurobindo Pharma has received tentative approval from FDA to produce 300 mg tablets of abacavir sulfate, which is used in combination with other antiretroviral drugs to treat HIV-1 infection, the company announced on Tuesday, the Hindu Business Line reports. Abacavir is the generic version of GlaxoSmithKline's Ziagen. [click link for full article] ...
Related Topics
- Drug Safety
- Tarceva
- Abacavir tablets
- Prescription Drugs
- Abacavir, Zidovudine and Lamivudine
- Vaccine Testing & Approval
- Drug Side Effects
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Lamivudine
- Tacrolimus ointment
- Tysabri
- Thalidomide
- Mammography
- Abacavir Oral Solution
- Carcinogens
- Clinical Trials
- Celecoxib

Not Signed In -


